SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Wang, Yaju ^a   Rao, Vinay Kumar ^a   Kok, Wai Kay ^a   Roy, Dijendra Nath ^a   Sethi, Sumita ^a   Ling, Belinda Mei Tze ^a   Lee, Martin Beng Huat ^b   Taneja, Reshma ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CYCLIN D1; HISTONE DEACETYLASE 1; PROTEIN P21; SUMO PROTEIN; TRANSCRIPTION FACTOR STRA13; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME REPRESSION; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; GENE MUTATION; GROWTH INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SUMOYLATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN D1; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MOLECULAR CHAPERONES; MUTATION; NIH 3T3 CELLS; NUCLEAR PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SUMO-1 PROTEIN;

EID: 84865059939     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043137     Document Type: Article

References (43)

1. Yamada K, Miyamoto K, ((2005)) Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. Front Biosci 10:: 3151--3171.
2. Sun H, Ghaffari S, Taneja R, ((2007)) bHLH-O transcription factors in development and disease. Translational Oncogenomics 2:: 107--120.
3. Boudjelal M, Taneja R, Shyuichiro M, Bouillet P, Dolle P, et al. ((1997)) Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev 11:: 2052--2065.
4. Sun H, Taneja R, ((2000)) Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc Natl Acad Sci U S A 97:: 4058--4063.
5. Sun H, Lu B, Li R-Q, Flavell RA, Taneja R, ((2001)) Defective T Cell activation and autoimmune disorder in Stra13-deficient mice Nat Immunology. 2:: 1040--1047.
6. Beadling C, Cereseto A, Fan W, Naramura M, Smith KA, ((2001)) Cytokine response gene 8 (CR8) regulates the cell cycle G1-S phase transition and promotes cellular survival. Oncogene 20:: 1771--1783.
7. Li Y, Zhang H, Xie M, Hu M, Ge S, et al. ((2002)) Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J 367:: 413--422.
8. Yun Z, Maecker HL, Johnson RS, Giaccia AJ, ((2002)) Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2:: 331--341.
9. Shen M, Yoshida E, Yan W, Kawamoto T, Suardita K, et al. ((2002)) Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem 277:: 50112--50120.
10. Seimiya M, Bahar R, Wang Y, Kawamura K, Tada Y, et al. ((2002)) Clast5/Stra13 is a negative regulator of B lymphocyte activation. Biochem Biophys Res Commun 292:: 121--127.
11. Grechez-Cassiau A, Panda S, Lacoche S, Teboul M, Azmi S, et al. ((2004)) The transcriptional repressor STRA13 regulates a subset of peripheral circadian outputs. J Biol Chem 279:: 1141--1150.
12. Qian Y, Zhang J, Yan B, Chen X, ((2008)) DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. 283:: 2896--2905.
13. Thin TH, Li L, Chung TK, Sun H, Taneja R, ((2007)) Stra13 is induced by genotoxic stress and regulates ionizing-radiation-induced apoptosis. EMBO Rep 8:: 401--407.
14. Sun H, Li L, Vercherat C, Gulbagci NT, Acharjee S, et al. ((2007)) Stra13 regulates satellite cell activation by antagonizing Notch signaling. J Cell Biol 177:: 647--657.
15. Vercherat C, Chung TK, Yalcin S, Gulbagci N, Gopinadhan S, et al. ((2009)) Stra13 regulates oxidative stress mediated skeletal muscle degeneration. Hum Mol Genet 18:: 4304--4316.
16. Miyazaki K, Miyazaki M, Guo Y, Yamasaki N, Kanno M, et al. ((2010)) The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells. J Immunol 185:: 7330--7339.
17. Bhawal UK, Sato F, Arakawa Y, Fujimoto K, Kawamoto T, et al. ((2011)) Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1. J Pathol 24:: 420--429.
18. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, et al. ((2003)) DEC1 (STRA13) protein expression relates to hypoxia-inducible factor1-alpha and carbonic anhydrase-9 overexpression in non small cell lung cancer. J Pathol 200:: 222--228.
19. Turley H, Wykoff CC, Troup S, Watson PH, Gatter KC, et al. ((2004)) The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumors. J Pathol 203:: 808--813.
20. Chakrabarti J, Turley H, Campo L, Han C, Harris AL, et al. ((2004)) The transcription factor DEC1 (Stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 91:: 954--958.
21. Ivanova A, Liao SY, Lerman MI, Ivanov S, Stanbridge EJ, ((2005)) STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. J Med Genet 42:: 565--576.
22. Zheng Y, Jia Y, Wang Y, Wang M, Li B, et al. ((2009)) The hypoxia-regulated transcription factor DEC1(Stra13, SHARP-2) and its expression in gastric cancer. Omics 13:: 301--306.
23. Fujimoto K, Hamaguchi H, Hashiba T, Nakamura T, Kawamoto T, et al. ((2007)) Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements. Int J Mol Med 19:: 925--932.
24. Ivanov SV, Salnikow K, Ivanova AV, Bai L, Lerman MI, ((2007)) Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene 26:: 802--812.
25. Muller S, Ledl A, Schmidt D, ((2004)) SUMO: a regulator of gene expression and genome integrity. Oncogene 23:: 1998--2008.
26. Geiss-Friedlander R, Melchior F, ((2007)) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8:: 947--956.
27. Melchior F, ((2000)) SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Bio 16:: 591--626.
28. Kotaja N, Karvonen U, Janne OA, Pavimo JJ, ((2002)) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligase. Mol Cell Biol 22:: 5222--5234.
29. Johnson ES, ((2004)) Protein modification by SUMO. Annu Rev Biochem 73:: 355--382.
30. Gill G, ((2005)) Something about SUMO inhibits transcription. Curr Opin Genet Dev 15:: 536--551.
31. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, et al. ((1999)) NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19:: 2690--2698.
32. Hong Y, Xing X, Li S, Bi H, Yang C, et al. ((2011)) SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS One 6:: e23046.
33. Verger A, Perdomo J, Crossley M, ((2003)) Modification with SUMO: A role in transcriptional regulation. EMBO Reports 4:: 137--143.
34. Grégoire S, Yang XJ, ((2005)) Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol Cell Biol 25:: 2273--2287.
35. Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, et al. ((2007)) An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol 27:: 2661--2675.
36. Lagger G, O'Carroll D, O'Carroll D, ((2002)) Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO Journal 21:: 2672--2681.
37. Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, et al. ((2010)) Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 24:: 455--469.
38. Glozak MA, Seto E, ((2007)) Histone deacetylases and cancer. Oncogene 26:: 5420--5432.
39. Marks PA, Xu WS, ((2009)) Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem 107:: 600--608.
40. Hayakawa F, Abe A, Kitabayashi I, Pandolfi PP, Naoe T, ((2008)) Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. J Biol Chem 283:: 24420--24425.
41. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaus M, et al. ((2005)) The DEAD-Box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol 25:: 1879--1889.
42. Liu JJ, Chung TK, Li J, Taneja R, ((2010)) Sharp-1 modulates the cellular response to DNA damage. FEBS Lett 584:: 619--624.
43. Ling BM, Bharathy N, Chung TK, Kok WK, Li S, et al. ((2012)) Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Natl Acad Sci U S A 109:: 841--846.